The prevalence of symptomatic hereditary CCM is 1:5400 to 1:6200.3 Notably, CCM3 mutation carriers often present with an earlier age of onset and a higher bleeding risk than CCM1 or CCM2 mutation carriers.4, 5, 6. Here, CCM2 is linked to cerebral cavernous malformation.